Xiaoyi Wang

517 total citations
21 papers, 412 citations indexed

About

Xiaoyi Wang is a scholar working on Pharmaceutical Science, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xiaoyi Wang has authored 21 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 6 papers in Biomedical Engineering and 3 papers in Biomaterials. Recurrent topics in Xiaoyi Wang's work include Advanced Drug Delivery Systems (9 papers), Drug Solubulity and Delivery Systems (7 papers) and Bone Tissue Engineering Materials (5 papers). Xiaoyi Wang is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Drug Solubulity and Delivery Systems (7 papers) and Bone Tissue Engineering Materials (5 papers). Xiaoyi Wang collaborates with scholars based in United States, China and Hong Kong. Xiaoyi Wang's co-authors include Diane J. Burgess, Yao Dong, Xinhui Xie, Ling Qin, Quanying Bao, Ge Zhang, Ruifeng Wang, Yan Wang, Yang Leng and Shih‐Chi Chen and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Infectious Diseases and Journal of Controlled Release.

In The Last Decade

Xiaoyi Wang

20 papers receiving 407 citations

Peers

Xiaoyi Wang
Yongyao Lin China
Ruowei Sun China
Hwiwon Lee South Korea
Amy E. Ross United States
Guiqiu Shan China
Nour Karra Israel
Yisheng Huang China
Xiaoyun Wang China
Hannah L. O’Mary United States
Natalia Salwowska Poland
Yongyao Lin China
Xiaoyi Wang
Citations per year, relative to Xiaoyi Wang Xiaoyi Wang (= 1×) peers Yongyao Lin

Countries citing papers authored by Xiaoyi Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Wang more than expected).

Fields of papers citing papers by Xiaoyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Wang. The network helps show where Xiaoyi Wang may publish in the future.

Co-authorship network of co-authors of Xiaoyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Wang. A scholar is included among the top collaborators of Xiaoyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Wang. Xiaoyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xiaoyi, et al.. (2025). Understanding drug release mechanisms of risperidone in situ forming implant depots in rabbits. Journal of Controlled Release. 383. 113785–113785. 1 indexed citations
3.
Wang, Xiaoyi, et al.. (2024). Towards in vitro – In vivo correlation models for in situ forming drug implants. Journal of Controlled Release. 372. 648–660. 7 indexed citations
4.
Wang, Xiaoyi, et al.. (2024). Long-acting injectable in situ forming implants: Impact of polymer attributes and API. International Journal of Pharmaceutics. 670. 125080–125080. 2 indexed citations
5.
Wang, Xiaoyi, Quanying Bao, Ruifeng Wang, et al.. (2023). Reverse engineering of Perseris and development of compositionally equivalent formulations. International Journal of Pharmaceutics. 639. 122948–122948. 14 indexed citations
6.
Wang, Xiaoyi, Quanying Bao, Ruifeng Wang, et al.. (2023). In situ forming risperidone implants: Effect of PLGA attributes on product performance. Journal of Controlled Release. 361. 777–791. 15 indexed citations
7.
Bao, Quanying, Xiaoyi Wang, Bo Wan, et al.. (2023). Development of in vitro-in vivo correlations for long-acting injectable suspensions. International Journal of Pharmaceutics. 634. 122642–122642. 11 indexed citations
8.
Wang, Xiaoyi, Quanying Bao, Ruifeng Wang, et al.. (2023). In vivo characterization of Perseris and compositionally equivalent formulations. International Journal of Pharmaceutics. 642. 123170–123170. 8 indexed citations
9.
Li, Shan, et al.. (2022). A retrospective analysis of data from illicit drug abuse cases in Beijing between 2018 and 2020. Legal Medicine. 58. 102086–102086. 2 indexed citations
10.
Bao, Quanying, Xiaoyi Wang, Yuan Zou, Yan Wang, & Diane J. Burgess. (2022). In vitro release testing method development for long-acting injectable suspensions. International Journal of Pharmaceutics. 622. 121840–121840. 23 indexed citations
11.
Wang, Xiaoyi, et al.. (2022). Novel adapter method for in vitro release testing of in situ forming implants. International Journal of Pharmaceutics. 621. 121777–121777. 17 indexed citations
12.
Wang, Xiaoyi & Diane J. Burgess. (2021). Drug release from in situ forming implants and advances in release testing. Advanced Drug Delivery Reviews. 178. 113912–113912. 70 indexed citations
13.
He, Jia, et al.. (2021). Strategies for extended lifetime of implantable intraperitoneal insulin catheters. Journal of Controlled Release. 341. 487–497. 4 indexed citations
14.
He, Jia, Éric Renard, J. Place, et al.. (2021). Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reaction. Journal of Controlled Release. 336. 1–15. 8 indexed citations
15.
Yang, Haitao, Weiming Tang, Ning Jiang, et al.. (2014). Worsening Epidemic of HIV and Syphilis Among Men Who Have Sex With Men in Jiangsu Province, China. Clinical Infectious Diseases. 58(12). 1753–1759. 31 indexed citations
16.
Lei, Ming, Xinhui Xie, Yao Dong, et al.. (2013). PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits. Acta Biomaterialia. 9(5). 6711–6722. 84 indexed citations
17.
18.
Xie, Xinhui, Xiaoyi Wang, Ge Zhang, et al.. (2011). Impaired bone healing in rabbits with steroid-induced osteonecrosis. Journal of Bone and Joint Surgery - British Volume. 93-B(4). 558–565. 26 indexed citations
19.
Mizokami, Tetsuya, Hiroko Hisha, Satoshi Okazaki, et al.. (2009). Preferential expansion of human umbilical cord blood-derived CD34-positive cells on major histocompatibility complex-matched amnion-derived mesenchymal stem cells. Haematologica. 94(5). 618–628. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongyao Lin Breakdown of academic impact, for papers by Ruowei Sun Breakdown of academic impact, for papers by Hwiwon Lee Breakdown of academic impact, for papers by Amy E. Ross Breakdown of academic impact, for papers by Guiqiu Shan Breakdown of academic impact, for papers by Nour Karra Breakdown of academic impact, for papers by Yisheng Huang Breakdown of academic impact, for papers by Xiaoyun Wang Breakdown of academic impact, for papers by Hannah L. O’Mary Breakdown of academic impact, for papers by Natalia Salwowska
Rankless by CCL
2026